Marker Therapeutics, Inc. (MRKR)

Latest Insider Confidence Score

2025Q4

50.2
Bullish

Company insider confidence (by quarter)

2004Q1 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Sonsini Peter W. 10% Owner 10,714,285 Mar 18, 2021
Makower Joshua 10% Owner 10,714,285 Mar 18, 2021
Viswanathan Ravi — 5,000,000 Oct 18, 2018
Mott David M — 5,000,000 Oct 18, 2018
Barris Peter J — 5,000,000 Oct 18, 2018

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 17, 2025 Nov 19, 2025 Knobil Katharine Director Neutral 52.5 - 0.00% ✗ -
Nov 17, 2025 Nov 19, 2025 Eansor Norman David Director Neutral 52.5 - 0.00% ✗ -
Nov 17, 2025 Nov 19, 2025 ELMS STEVE Director Neutral 52.5 - 0.00% ✗ -
Oct 31, 2025 Nov 4, 2025 Corzo Kathryn Penkus Director Neutral 52.5 - 0.00% ✗ -
Oct 31, 2025 Nov 4, 2025 Vera Juan CEO Neutral 52.5 - 0.00% ✗ -
Nov 4, 2025 Corzo Kathryn Penkus Director Neutral 52.5 - 0.00% ✗ -
Feb 12, 2025 Feb 14, 2025 ELMS STEVE Director Neutral 52.5 - 0.00% ✗ -
Feb 12, 2025 Feb 14, 2025 Knobil Katharine Director Neutral 52.5 - 0.00% ✗ -
Feb 12, 2025 Feb 14, 2025 Eansor Norman David Director Neutral 52.5 - 0.00% ✗ -
Feb 12, 2025 Feb 14, 2025 Vera Juan CEO Neutral 52.5 - 0.00% ✗ -
Dec 23, 2024 Dec 26, 2024 ELMS STEVE Director Buy 83.8 +11,085 3.49% ✗ $35.5K
Dec 23, 2024 Dec 23, 2024 New Enterprise Associates 16, L.P. 10% Owner Buy 100.0 +554,250 51.73% ✗ $1.8M
Jul 5, 2023 Lurier Eliot M CFO Neutral 52.5 - 0.00% ✗ -
Mar 16, 2021 Jun 8, 2023 Eansor Norman David Director Buy 95.0 +14,284 588.30% ✗ $250K
Jun 6, 2023 Jun 8, 2023 Knobil Katharine Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 8, 2023 Wilson John Robert Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 8, 2023 ELMS STEVE Director Neutral 52.5 - 0.00% ✗ -
May 10, 2023 May 11, 2023 Vera Juan CEO Neutral 52.5 - 0.00% ✗ -
Feb 27, 2023 Mar 1, 2023 Hoang Tsvetelina P VP, Research and Development Neutral 52.5 - 0.00% ✗ -
Feb 27, 2023 Mar 1, 2023 Koneru Mythili Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 27, 2023 Mar 1, 2023 Loiacono Michael Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Feb 27, 2023 Mar 1, 2023 Vera Juan COO Neutral 52.5 - 0.00% ✗ -
Feb 27, 2023 Mar 1, 2023 Szymanska Anna President Neutral 52.5 - 0.00% ✗ -
Feb 27, 2023 Mar 1, 2023 Agopyan Nadia SVP, Regulatory Affairs Neutral 52.5 - 0.00% ✗ -
May 24, 2022 May 26, 2022 Wilson John Robert Director Neutral 52.5 - 0.00% ✗ -
May 24, 2022 May 26, 2022 Laskow-Pooley David Director Neutral 52.5 - 0.00% ✗ -
May 24, 2022 May 26, 2022 Knobil Katharine Director Neutral 52.5 - 0.00% ✗ -
May 24, 2022 May 26, 2022 ELMS STEVE Director Neutral 52.5 - 0.00% ✗ -
May 24, 2022 May 26, 2022 Eansor Norman David Director Neutral 52.5 - 0.00% ✗ -
Mar 24, 2022 Mar 28, 2022 Hoang Peter L. CEO Sell 91.3 +150,718 45.32% ✗ $23.5K
Mar 24, 2022 Mar 28, 2022 Vera Juan COO Sell 83.8 +107,358 4.19% ✗ $16.2K
Mar 24, 2022 Mar 28, 2022 Kim Anthony H. CFO Sell 91.3 +114,436 100.00% ✗ $17.5K
Feb 17, 2022 Feb 22, 2022 Hoang Peter L. CEO Neutral 52.5 - 0.00% ✗ -
Feb 17, 2022 Feb 22, 2022 Vera Juan COO Neutral 52.5 - 0.00% ✗ -
Feb 17, 2022 Feb 22, 2022 Szymanska Anna President Neutral 52.5 - 0.00% ✗ -
Feb 17, 2022 Feb 22, 2022 Loiacono Michael Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Feb 17, 2022 Feb 22, 2022 Koneru Mythili Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 17, 2022 Feb 22, 2022 Kim Anthony H. CFO Neutral 52.5 - 0.00% ✗ -
Feb 17, 2022 Feb 22, 2022 Hoang Tsvetelina P VP, Research and Development Neutral 52.5 - 0.00% ✗ -
Feb 17, 2022 Feb 22, 2022 Garrett Gerald President Neutral 52.5 - 0.00% ✗ -
Feb 17, 2022 Feb 22, 2022 Agopyan Nadia VP, Regulatory Affairs Neutral 52.5 - 0.00% ✗ -
Dec 8, 2021 Dec 9, 2021 Knobil Katharine Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2021 Knobil Katharine Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2021 Jun 10, 2021 Wasserman Frederick Gerald Director Neutral 90.0 +12,658 24.08% ✗ -
Jun 8, 2021 Jun 10, 2021 Laskow-Pooley David Director Neutral 90.0 +12,658 29.74% ✗ -
Jun 8, 2021 Jun 10, 2021 ELMS STEVE Director Neutral 60.0 +12,658 0.40% ✗ -
Jun 8, 2021 Jun 10, 2021 Eansor Norman David Director Neutral 90.0 +12,658 52.13% ✗ -
Jun 8, 2021 Jun 10, 2021 Wilson John Robert Director Neutral 55.0 +12,658 0.16% ✗ -
May 18, 2021 May 20, 2021 Wasserman Frederick Gerald Director Buy 91.3 +10,000 23.49% ✗ $24.1K
Mar 16, 2021 Mar 18, 2021 Walker Paul Edward 10% Owner Buy 100.0 +5,714,285 114.29% ✗ $10M
Mar 16, 2021 Mar 18, 2021 Sonsini Peter W. 10% Owner Buy 100.0 +5,714,285 114.29% ✗ $10M
Mar 16, 2021 Mar 18, 2021 SANDELL SCOTT D 10% Owner Buy 100.0 +5,714,285 114.29% ✗ $10M
Mar 16, 2021 Mar 18, 2021 MAKOWER JOSHUA 10% Owner Buy 100.0 +5,714,285 114.29% ✗ $10M
Mar 16, 2021 Mar 18, 2021 Makhzoumi Mohamad 10% Owner Buy 100.0 +5,714,285 114.29% ✗ $10M
Mar 16, 2021 Mar 18, 2021 Florence Anthony A. Jr. 10% Owner Buy 100.0 +5,714,285 114.29% ✗ $10M
Mar 16, 2021 Mar 18, 2021 Chang Carmen 10% Owner Buy 100.0 +5,714,285 114.29% ✗ $10M
Mar 16, 2021 Mar 18, 2021 Behbahani Ali 10% Owner Buy 100.0 +5,714,285 114.29% ✗ $10M
Mar 16, 2021 Mar 18, 2021 BASKETT FOREST 10% Owner Buy 100.0 +5,714,285 114.29% ✗ $10M
Mar 16, 2021 Mar 18, 2021 New Enterprise Associates 16, L.P. 10% Owner Buy 100.0 +5,714,285 114.29% ✗ $10M
Mar 16, 2021 Mar 18, 2021 Wilson John Robert Director Buy 100.0 +1,714,285 28.17% ✗ $3M
Mar 16, 2021 Mar 18, 2021 Vera Juan Chief Development Officer Buy 97.5 +571,428 28.67% ✗ $1000K
Mar 16, 2021 Mar 18, 2021 Hoang Peter L. CEO Buy 95.0 +142,857 75.30% ✗ $250K
Mar 16, 2021 Mar 18, 2021 ELMS STEVE Director Buy 100.0 +1,142,857 56.66% ✗ $2M
Feb 24, 2021 Leen Ann M. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Feb 10, 2021 Feb 12, 2021 Vera Juan Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Feb 10, 2021 Feb 12, 2021 Szymanska Anna President Neutral 52.5 - 0.00% ✗ -
Feb 10, 2021 Feb 12, 2021 Loiacono Michael Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Feb 10, 2021 Feb 12, 2021 Koneru Mythili Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 10, 2021 Feb 12, 2021 Kim Anthony H. CFO Neutral 52.5 - 0.00% ✗ -
Feb 10, 2021 Feb 12, 2021 Hoang Tsvetelina P VP, Research and Development Neutral 52.5 - 0.00% ✗ -
Feb 11, 2021 Feb 12, 2021 Hoang Peter L. CEO Neutral 52.5 - 0.00% ✗ -
Feb 10, 2021 Feb 12, 2021 Garrett Gerald President Neutral 52.5 - 0.00% ✗ -
Feb 10, 2021 Feb 12, 2021 Agopyan Nadia VP, Regulatory Affairs Neutral 52.5 - 0.00% ✗ -
May 19, 2020 Feb 12, 2021 Wilson John Robert Director Neutral 60.0 +17,022 0.28% ✗ -
May 19, 2020 Feb 12, 2021 Wasserman Frederick Gerald Director Neutral 90.0 +17,022 66.64% ✗ -
May 19, 2020 Feb 12, 2021 Laskow-Pooley David Director Neutral 90.0 +17,022 66.64% ✗ -
May 19, 2020 Feb 12, 2021 ELMS STEVE Director Neutral 67.5 +17,022 0.85% ✗ -
May 19, 2020 Feb 12, 2021 Eansor Norman David Director Neutral 90.0 +17,022 234.46% ✗ -
Nov 13, 2020 Eastern Capital LTD 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 16, 2020 Jun 19, 2020 Eastern Capital LTD 10% Owner Neutral 52.5 - 0.00% ✗ -
Mar 10, 2020 Mar 12, 2020 Hoang Peter L. CEO Neutral 52.5 - 0.00% ✗ -
Mar 10, 2020 Mar 12, 2020 Vera Juan Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Mar 10, 2020 Mar 12, 2020 Szymanska Anna President Neutral 52.5 - 0.00% ✗ -
Mar 10, 2020 Mar 12, 2020 Loiacono Michael Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Mar 10, 2020 Mar 12, 2020 Koneru Mythili Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 10, 2020 Mar 12, 2020 Kim Anthony H. CFO Neutral 52.5 - 0.00% ✗ -
Mar 10, 2020 Mar 12, 2020 Hoang Tsvetelina P VP, Research and Development Neutral 52.5 - 0.00% ✗ -
Mar 10, 2020 Mar 12, 2020 Garrett Gerald President Neutral 52.5 - 0.00% ✗ -
Mar 10, 2020 Mar 12, 2020 Agopyan Nadia VP, Regulatory Affairs Neutral 52.5 - 0.00% ✗ -
Mar 12, 2020 Szymanska Anna President Neutral 52.5 - 0.00% ✗ -
Mar 12, 2020 Garrett Gerald President Neutral 52.5 - 0.00% ✗ -
Feb 18, 2020 Feb 20, 2020 Eastern Capital LTD 10% Owner Neutral 52.5 - 0.00% ✗ -
Aug 15, 2019 Aug 19, 2019 Agopyan Nadia VP, Regulatory Affairs Neutral 52.5 - 0.00% ✗ -
Aug 19, 2019 Agopyan Nadia VP, Regulatory Affairs Neutral 52.5 - 0.00% ✗ -
Aug 14, 2019 Aug 15, 2019 Hoang Peter L. CEO Buy 86.3 +10,000 5.56% ✗ $46.2K
Aug 6, 2019 Aug 8, 2019 ELMS STEVE Director Neutral 52.5 - 0.00% ✗ -
Aug 8, 2019 ELMS STEVE Director Neutral 52.5 - 0.00% ✗ -
May 15, 2019 Koneru Mythili Snr VP, Clinical Development Neutral 52.5 - 0.00% ✗ -
May 9, 2019 May 13, 2019 Eansor Norman David Director Neutral 90.0 +7,260 100.00% ✗ -
May 9, 2019 May 13, 2019 Wilson John Robert Director Neutral 55.0 +7,260 0.12% ✗ -